Tag | Content |
---|
EnhancerAtlas ID | HS176-03304 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr1:203517990-203518840 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
HNF4G | MA0484.1 | chr1:203518727-203518742 | ACAGGACAAAGGCCA | + | 6.03 | RREB1 | MA0073.1 | chr1:203518607-203518627 | GGGGTGGGGGTGGGGTGGAG | - | 6.62 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_00433 | chr1:203513781-203518813 | Adipose_Nuclei | SE_40925 | chr1:203517827-203518906 | Left_Ventricle | SE_46073 | chr1:203517538-203518872 | Osteoblasts | SE_55853 | chr1:203516457-203518914 | u87 | SE_67709 | chr1:203516457-203518914 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I203549 | chr1 | 203518348 | 203519397 |
|
Enhancer Sequence | AAATCAGCAT GCAAATGTGA TGAGCATAGA AGAAACAAAG CTGGTGAAAT AAACACATGC 60 GATAAAAGGA CAGAGAAAGC AGAATAAATG TAGGAAAGAA TCTAATTCTC CAGAACTTCA 120 GAGCCAAAAG GGGCCTCGGG GATCAGCTGA CAAACCCCTT AGTAACAGAA CCTTCCCAGC 180 AGCCTTTATT TCCCCACATC TCTCTTACAT TTTGCCAAAG ATAATATTCA CTTTGATGTT 240 GCAAAAGCTT TAGTTTGCTT GTTGTGTTTC CTCTCTCCAT AATGGTATGT TAGGCCATCC 300 TTTTGTATTG GCAAATTGGT CTGACAAAAA GAGCATTATA AATTGTGAAA ATACAAACAA 360 ATTCTCCCAG CTCTGAAATT CTCCTTGGAC TTCAGTGGTT GACACAAATA ATTTAGAGGT 420 GATGGAGTTC CTTGAGTGCA GAGGGTGACA GAAGTTCATT CTTCCTCTGG CAAAGAGAGA 480 GAGAGAGAGC TGTCTCCCTG CAGTTTGGGA GACTGGGCAA CCACTCTCTA GGGATGCTAC 540 AGAGCTTGCT GTCCTCCCTC CTTCCAGACA GGTTGGCAGT CCTGCTGAAA GCTGACTCCT 600 CTTTCCTGAA AGTCTATGGG GTGGGGGTGG GGTGGAGGAG TGCTATGCAT CCAGGTGCCC 660 CGCTCTGGTG TAACCTGAGA CTAGAAGGCA ACTATATTCC AGGCTTTTGA GAATACTGAG 720 TCAGGGTAAT GGGGATGACA GGACAAAGGC CAGGCAGGAC ATGCTGGAAT TTGTTTTTGT 780 TTTGTTTTGT TTTTTGAGAC AGAGTTTCAC TCTTGTTGCC CAGGCTGGAG TGCAGTGGCG 840 CTATCTCAGC 850
|